<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35426263</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2324-9269</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular genetics &amp; genomic medicine</Title><ISOAbbreviation>Mol Genet Genomic Med</ISOAbbreviation></Journal><ArticleTitle>Quadruple genetic variants in a sporadic ALS patient.</ArticleTitle><Pagination><StartPage>e1953</StartPage><MedlinePgn>e1953</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/mgg3.1953</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Due to upcoming gene-specific therapy approaches for ALS patients, understanding familial and sporadic ALS genetics is becoming increasingly important. In this study, we wanted to investigate underlying genetic causes for an SALS patient.</AbstractText><AbstractText Label="METHODS">We performed ALS gene panel sequencing and subsequent segregation analysis in the family.</AbstractText><AbstractText Label="RESULTS">Genetic studies suggest that a proportion of SALS cases has an oligogenic origin due to the combination of low-effect size mutations in several ALS genes. Maximally three mutations in different ALS disease genes have been described in isolated ALS patients. Here, we report for the first time the co-occurrence of rare nonsynonymous variants in four known ALS genes in a SALS patient (c.859G&#x2009;&gt;&#x2009;A/p.Gly287Ser in TARDBP, c.304G&#x2009;&gt;&#x2009;T/p.Glu102* in NEK1, c.3446C&#x2009;&gt;&#x2009;A/p.Gly1149Val in ERBB4, and c.1015C&#x2009;&gt;&#x2009;T/p.Arg339Trp in VEGFA). All four variants were unique for the patient, whereas up to three of these variants were detected in the unaffected family members, all older than the patient.</AbstractText><AbstractText Label="DISCUSSION">Our study suggests that SALS can be caused by the additive or synergistic action of low-effect size mutations. Broader use of gene panel analysis or whole exome/genome sequencing may reveal a potentially treatable oligogenic causation in a higher percentage of SALS than previously thought.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Molecular Genetics &amp; Genomic Medicine published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>R&#xfc;stem</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4261-5236</Identifier><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Kanchi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valkadinov</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knehr</LastName><ForeName>Antje</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenner</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1535-3146</Identifier><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Genet Genomic Med</MedlineTA><NlmUniqueID>101603758</NlmUniqueID><ISSNLinking>2324-9269</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">oligogenic inheritance</Keyword><Keyword MajorTopicYN="N">sporadic ALS</Keyword></KeywordList><CoiStatement>There are no competing interests for any author.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35426263</ArticleId><ArticleId IdType="pmc">PMC9266611</ArticleId><ArticleId IdType="doi">10.1002/mgg3.1953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cady, J. , Allred, P. , Bali, T. , Pestronk, A. , Goate, A. , Miller, T. M. , Mitra, R. D. , Ravits, J. , Harms, M. B. , &amp; Baloh, R. H. (2015). Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Annals of Neurology, 77(1), 100&#x2013;113. 10.1002/ana.24306 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado, L. , Ratti, A. , Gellera, C. , Buratti, E. , Castellotti, B. , Carlomagno, Y. , Ticozzi, N. , Mazzini, L. , Testa, L. , Taroni, F. , &amp; Baralle, F. E. (2009). High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Human Mutation, 30(4), 688&#x2013;694. 10.1002/humu.20950 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20950</ArticleId><ArticleId IdType="pubmed">19224587</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin, J. , Catanese, A. , Semelink&#x2010;Sedlacek, L. L. , Oeztuerk, S. , Lutz, A. K. , Bausinger, J. , Barbi, G. , Speit, G. , Andersen, P. M. , Ludolph, A. C. , &amp; Demestre, M. (2018). NEK1 loss&#x2010;of&#x2010;function mutation induces DNA damage accumulation in ALS patient&#x2010;derived motoneurons. Stem Cell Research, 30, 150&#x2013;162. 10.1016/j.scr.2018.06.005 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.06.005</ArticleId><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi, E. , Valdmanis, P. N. , Dion, P. , Spiegelman, D. , BJ, M. C. , Velde, C. V. , Bouchard, J. P. , Lacomblez, L. , Pochigaeva, K. , Salachas, F. , &amp; Pradat, P. F. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nature Genetics, 40(5), 572&#x2013;574. 10.1038/ng.132 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby, J. , Goodall, E. F. , Smith, W. , Highley, J. R. , Masanzu, R. , Hartley, J. A. , Hibberd, R. , Hollinger, H. C. , Wharton, S. B. , Morrison, K. E. , &amp; Ince, P. G. (2010). Broad clinical phenotypes associated with TAR&#x2010;DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics, 11(2), 217&#x2013;225. 10.1007/s10048-009-0218-9 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-009-0218-9</ArticleId><ArticleId IdType="pubmed">19760257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo, B. R. , &amp; Erickson, C. A. (2010). Regional differences in neural crest morphogenesis. Cell Adhesion &amp; Migration, 4(4), 567&#x2013;585. 10.4161/cam.4.4.12890 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.4.4.12890</ArticleId><ArticleId IdType="pmc">PMC3011260</ArticleId><ArticleId IdType="pubmed">20962585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, F. , &amp; Ruhrberg, C. (2012). Diverse roles for VEGF&#x2010;A in the nervous system. Development, 139(8), 1371&#x2013;1380. 10.1242/dev.072348 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.072348</ArticleId><ArticleId IdType="pubmed">22434866</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini, R. , Flynn, L. L. , Pitout, I. L. , Fletcher, S. , Wilton, S. D. , &amp; Akkari, P. A. (2019). ALS genetics, mechanisms, and therapeutics: Where are we now? Frontiers in Neuroscience, 13, 1310. 10.3389/fnins.2019.01310 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra, J. , &amp; Hegde, M. L. (2019). A commentary on TDP&#x2010;43 and DNA damage response in amyotrophic lateral sclerosis. Journal of Experimental Neuroscience, 13, 1179069519880166. 10.1177/1179069519880166 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519880166</ArticleId><ArticleId IdType="pmc">PMC6791036</ArticleId><ArticleId IdType="pubmed">31656396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, H. P. , Van Broeckhoven, C. , &amp; van der Zee, J. (2018). ALS genes in the genomic era and their implications for FTD. Trends in Genetics, 34(6), 404&#x2013;423. 10.1016/j.tig.2018.03.001 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi, Y. , Fukuda, Y. , Yoshimura, J. , Toyoda, A. , Kurppa, K. , Moritoyo, H. , Belzil, V. V. , Dion, P. A. , Higasa, K. , Doi, K. , &amp; Ishiura, H. (2013). ERBB4 mutations that disrupt the neuregulin&#x2010;ErbB4 pathway cause amyotrophic lateral sclerosis type 19. American Journal of Human Genetics, 93(5), 900&#x2013;905. 10.1016/j.ajhg.2013.09.008 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck, L. , Kleinberger, G. , Chapuis, J. , Gistelinck, M. , Amouyel, P. , Van Broeckhoven, C. , Lambert, J. C. , Callaerts, P. , &amp; Dermaut, B. (2015). Functional complementation in drosophila to predict the pathogenicity of TARDBP variants: Evidence for a loss&#x2010;of&#x2010;function mechanism. Neurobiology of Aging, 36(2), 1121&#x2013;1129. 10.1016/j.neurobiolaging.2014.09.001 [published Online First: Epub Date].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.09.001</ArticleId><ArticleId IdType="pubmed">25442115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>